<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药前途汇 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-13T16:57:44+08:00</updated>
  <subtitle>「前途汇」通过网络和线下聚会：分享和传报全球医药行业信息资讯、技术项目、并购资源、代理品种。建立医药行业国际化的沟通桥梁、交易平台、学习园地。是中国医药行业人脉拓展、商务交流的“好圈子”。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>纵览全国仿制药研发目录，做好2021年研发准备工作（下）</title>
    <updated>2021-01-13T15:15:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/eghTLlW2xo1GHoB5l_aMbA</id>
    <link href="https://mp.weixin.qq.com/s/eghTLlW2xo1GHoB5l_aMbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CRO会员】高技术壁垒药物研发平台“上海博悦”合作项目推荐</title>
    <updated>2021-01-13T15:15:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/DGBnhaVP4GjfbNkR7awvug</id>
    <link href="https://mp.weixin.qq.com/s/DGBnhaVP4GjfbNkR7awvug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>政策解读《国家药品监督管理局关于促进中药传承创新发展的实施意见》</title>
    <updated>2021-01-12T10:54:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/h8tRdGZBQEOd1TRJkoZBlQ</id>
    <link href="https://mp.weixin.qq.com/s/h8tRdGZBQEOd1TRJkoZBlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>20年专做委托生产，普德药业从注册申报到生产和营销的一体化CMO服务商</title>
    <updated>2021-01-12T10:54:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/kT-uVlX85fz7JNBacQUJNQ</id>
    <link href="https://mp.weixin.qq.com/s/kT-uVlX85fz7JNBacQUJNQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【转让】广谱青霉素“哌拉西林”的双腔袋剂型制剂技术（开发已完成）</title>
    <updated>2021-01-12T10:54:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/Yh42IjSjAnH1pYPq7xmrzg</id>
    <link href="https://mp.weixin.qq.com/s/Yh42IjSjAnH1pYPq7xmrzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>纵览全国仿制药研发目录，做好2021年研发准备工作（上）</title>
    <updated>2021-01-11T15:12:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/iMwCOXzpbMqYlM2spTDu1w</id>
    <link href="https://mp.weixin.qq.com/s/iMwCOXzpbMqYlM2spTDu1w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【转让】FDA批准的类风湿性关节炎新靶点药物--“枸橼酸托法替布”（已完成中试）</title>
    <updated>2021-01-11T15:12:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/ru3U9TkGAxoFCAJe_btO4Q</id>
    <link href="https://mp.weixin.qq.com/s/ru3U9TkGAxoFCAJe_btO4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【演讲预告】从仿制药到改良型新药的跨越之路</title>
    <updated>2021-01-11T15:12:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/m2eYHpWiegmbhqve7mJaXA</id>
    <link href="https://mp.weixin.qq.com/s/m2eYHpWiegmbhqve7mJaXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这些重磅医药政策2021年开始实行！</title>
    <updated>2021-01-08T15:17:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/KV7LsPVFLa0-1Q8UqQ_eNg</id>
    <link href="https://mp.weixin.qq.com/s/KV7LsPVFLa0-1Q8UqQ_eNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【参观名企】前途汇邀您走进特色CRO企业“杭州百诚医药”</title>
    <updated>2021-01-08T15:17:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/SzOFrWdJGdgQpNRpiOoEyg</id>
    <link href="https://mp.weixin.qq.com/s/SzOFrWdJGdgQpNRpiOoEyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【转让】帕金森患者的福音--“阿扑吗啡舌下膜”（已完成中试）</title>
    <updated>2021-01-08T15:17:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/1UVPaw0ux2qqajMzpHFwXw</id>
    <link href="https://mp.weixin.qq.com/s/1UVPaw0ux2qqajMzpHFwXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年值得开发的新药/仿制药推荐之“神经系统用药”系列（成熟技术）</title>
    <updated>2021-01-07T15:10:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/w8GZXEBY2IYYTaTrALXNyA</id>
    <link href="https://mp.weixin.qq.com/s/w8GZXEBY2IYYTaTrALXNyA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【转让】不用做临床的儿童新药--复方聚乙二醇电解质散（儿童型）</title>
    <updated>2021-01-07T15:10:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/ZuoHCa8ogeHgzSnOybNb8A</id>
    <link href="https://mp.weixin.qq.com/s/ZuoHCa8ogeHgzSnOybNb8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【资金规模缩水】盘点2020年全球生物医药领域十大并购事件</title>
    <updated>2021-01-06T15:58:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/ql3UWp4wgffhATL4-GEtoQ</id>
    <link href="https://mp.weixin.qq.com/s/ql3UWp4wgffhATL4-GEtoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CRO会员】北京海步医药API关联及制剂技术转让“项目推荐”</title>
    <updated>2021-01-06T15:58:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/yyketHEXpOXyez07hIYa6Q</id>
    <link href="https://mp.weixin.qq.com/s/yyketHEXpOXyez07hIYa6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【分论坛邀请函】双循环格局下药企的开放式创新（药智网）</title>
    <updated>2021-01-06T15:58:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/nLJ-9_j9Po866mxTEK63rA</id>
    <link href="https://mp.weixin.qq.com/s/nLJ-9_j9Po866mxTEK63rA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品代理商如何成为产品持有人？案例分析来了</title>
    <updated>2021-01-05T15:26:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/xMcXN92ntP7Gt0DKFUSc1g</id>
    <link href="https://mp.weixin.qq.com/s/xMcXN92ntP7Gt0DKFUSc1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CRO会员】上海博志研新可合作“新药项目”推荐</title>
    <updated>2021-01-05T15:26:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/h_-d5l6H4v6fH7ryaNarDg</id>
    <link href="https://mp.weixin.qq.com/s/h_-d5l6H4v6fH7ryaNarDg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【盘点】2021年Q1即将获批重磅药物</title>
    <updated>2021-01-04T15:58:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/C7SY-P1m_Hf2pvjVGLirWg</id>
    <link href="https://mp.weixin.qq.com/s/C7SY-P1m_Hf2pvjVGLirWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>拥有6大生产基地：京新药业可提供国际标准的口服固体制剂CMO服务</title>
    <updated>2021-01-04T15:58:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/j0rppr5ss7Et3_BmxrP9QA</id>
    <link href="https://mp.weixin.qq.com/s/j0rppr5ss7Et3_BmxrP9QA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>